One pathway
7 Still, Le, who is also a general surgery registrar at Royal Melbourne Hospital, says, I think it is too early to say this is a robust, durable, and generalizable effect given the high heterogeneity of underlying studies. He notes a need for more rigorous randomized controlled trials with longer follow-up times to better characterize the impact of these medications on weight and OSA together, as well as gain a better understanding of effect size, optimal doses, side effects, interactions with other medications, and impacts on other comorbidities
While GLP-1-RAs have been shown to lower the risk of serious heart and stroke complications in the general population with type 2 diabetes, their effects on individuals with autoimmune diseases have not been thoroughly investigated
These include neurological damage and a higher risk of heart disease
Side effects of Incretin Mimetics or GLP-1 drugs may be the result of the way they work in the human body
Next, a doctor or other prescribing clinician will review your results and provide a prescription if appropriate